These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 26987610)

  • 1. Optimising the controlled release of dexamethasone from a new generation of PLGA-based microspheres intended for intravitreal administration.
    Rodríguez Villanueva J; Bravo-Osuna I; Herrero-Vanrell R; Molina Martínez IT; Guzmán Navarro M
    Eur J Pharm Sci; 2016 Sep; 92():287-97. PubMed ID: 26987610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
    Duvvuri S; Janoria KG; Pal D; Mitra AK
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sulfate polysaccharide/TNF-related apoptosis-inducing ligand (TRAIL) complex for the long-term delivery of TRAIL in poly(lactic-co-glycolic acid) (PLGA) microspheres.
    Kim H; Jeong D; Kang HE; Lee KC; Na K
    J Pharm Pharmacol; 2013 Jan; 65(1):11-21. PubMed ID: 23215683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dexamethasone-loaded PLGA microspheres on human fetal osteoblasts.
    Dawes GJ; Fratila-Apachitei LE; Necula BS; Apachitei I; van Leeuwen JP; Duszczyk J; Eijken M
    J Biomater Appl; 2012 Nov; 27(4):477-83. PubMed ID: 21862514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled delivery of tauroursodeoxycholic acid from biodegradable microspheres slows retinal degeneration and vision loss in P23H rats.
    Fernández-Sánchez L; Bravo-Osuna I; Lax P; Arranz-Romera A; Maneu V; Esteban-Pérez S; Pinilla I; Puebla-González MDM; Herrero-Vanrell R; Cuenca N
    PLoS One; 2017; 12(5):e0177998. PubMed ID: 28542454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal administration of dexamethasone-loaded PLGA-TPGS nanoparticles for the treatment of posterior segment diseases.
    Yang C; Jiang L; Bu S; Zhang L; Xie X; Zeng Q; Zhu D; Zheng Y
    J Biomed Nanotechnol; 2013 Sep; 9(9):1617-23. PubMed ID: 23980509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release.
    Song X; Song SK; Zhao P; Wei LM; Jiao HS
    Pharm Dev Technol; 2013; 18(5):1220-9. PubMed ID: 22295954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance of high and low amounts of PLGA microspheres loaded with mineralocorticoid receptor antagonist in retinal target site.
    Zhao M; Rodríguez-Villagra E; Kowalczuk L; Le Normand M; Berdugo M; Levy-Boukris R; El Zaoui I; Kaufmann B; Gurny R; Bravo-Osuna I; Molina-Martínez IT; Herrero-Vanrell R; Behar-Cohen F
    J Control Release; 2017 Nov; 266():187-197. PubMed ID: 28947395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six month delivery of GDNF from PLGA/vitamin E biodegradable microspheres after intravitreal injection in rabbits.
    García-Caballero C; Prieto-Calvo E; Checa-Casalengua P; García-Martín E; Polo-Llorens V; García-Feijoo J; Molina-Martínez IT; Bravo-Osuna I; Herrero-Vanrell R
    Eur J Pharm Sci; 2017 May; 103():19-26. PubMed ID: 28259830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the test method on in vitro drug release from intravitreal model implants containing dexamethasone or fluorescein sodium in poly (d,l-lactide-co-glycolide) or polycaprolactone.
    Stein S; Auel T; Kempin W; Bogdahn M; Weitschies W; Seidlitz A
    Eur J Pharm Biopharm; 2018 Jun; 127():270-278. PubMed ID: 29490233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zero order controlled release delivery of cholecalciferol from injectable biodegradable microsphere: In-vitro characterization and in-vivo pharmacokinetic studies.
    Vora L; V G S; Vavia P
    Eur J Pharm Sci; 2017 Sep; 107():78-86. PubMed ID: 28629804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photoreceptor preservation induced by intravitreal controlled delivery of GDNF and GDNF/melatonin in rhodopsin knockout mice.
    García-Caballero C; Lieppman B; Arranz-Romera A; Molina-Martínez IT; Bravo-Osuna I; Young M; Baranov P; Herrero-Vanrell R
    Mol Vis; 2018; 24():733-745. PubMed ID: 30581280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer.
    He J; Feng M; Zhou X; Ma S; Jiang Y; Wang Y; Zhang H
    Int J Pharm; 2011 Sep; 416(1):69-76. PubMed ID: 21699969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly bioactive, bevacizumab-loaded, sustained-release PLGA/PCADK microspheres for intravitreal therapy in ocular diseases.
    Liu J; Li S; Li G; Li X; Yu C; Fu Z; Li X; Teng L; Li Y; Sun F
    Int J Pharm; 2019 May; 563():228-236. PubMed ID: 30959236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation.
    Su ZX; Shi YN; Teng LS; Li X; Wang LX; Meng QF; Teng LR; Li YX
    Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations.
    Zhang Z; Wang X; Li B; Hou Y; Yang J; Yi L
    Drug Deliv; 2018 Nov; 25(1):166-177. PubMed ID: 29299936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional hydrogel-based scaffold for improving the functionality of encapsulated therapeutic cells and reducing inflammatory response.
    Acarregui A; Herrán E; Igartua M; Blanco FJ; Pedraz JL; Orive G; Hernandez RM
    Acta Biomater; 2014 Oct; 10(10):4206-16. PubMed ID: 25010523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma.
    Arranz-Romera A; Davis BM; Bravo-Osuna I; Esteban-Pérez S; Molina-Martínez IT; Shamsher E; Ravindran N; Guo L; Cordeiro MF; Herrero-Vanrell R
    J Control Release; 2019 Mar; 297():26-38. PubMed ID: 30664980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.
    Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM
    Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasone.
    Barcia E; Herrero-Vanrell R; Díez A; Alvarez-Santiago C; López I; Calonge M
    Exp Eye Res; 2009 Aug; 89(2):238-45. PubMed ID: 19341729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.